Status:
COMPLETED
Gait Analysis in MPS IVA
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
University of Utah
BioMarin Pharmaceutical
Conditions:
MPS IVA
Morquio Syndrome
Eligibility:
All Genders
1+ years
Brief Summary
The purpose of this study is to learn about gait (walking) characteristics in MPS IVA and possible changes in gait with enzyme replacement therapy.
Detailed Description
The purpose of this 3-year study is to conduct a longitudinal investigation using motion analysis of gait to objectively and quantitatively assess gait characteristics of MPS IVA patients. Data docume...
Eligibility Criteria
Inclusion
- Diagnosis of MPS IVA
Exclusion
- Non-ambulatory
- Previous enrolled in clinical trial BMN-110
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01920828
Start Date
August 1 2013
End Date
June 1 2017
Last Update
October 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health and Science University
Portland, Oregon, United States, 97239